Beiersdorf (BEI) Q4 2025 earnings summary

Executive summary

• Navigated a year of economic and geopolitical uncertainty, achieving 2.4% organic group sales growth to €9.9 billion in 2025, with EBIT margin at 14.0%.

• Maintained position as the best performing global skincare company, with derma and healthcare segments delivering double-digit growth.

• NIVEA saw modest 0.9% organic growth amid strategic repositioning and recalibration, while La Prairie declined 4.5% organically.

• Innovation and expansion into new markets, including white space expansion, remained key strategic pillars.

• tesa achieved €1.7 billion in sales, up 1.8% organically, despite challenging market conditions.

Financial highlights

• Group net sales grew to €9.852 billion in 2025, with organic sales growth of 2.4% and EBIT margin at 14.0%.

• Earnings per share rose to €4.25, up 4.9% from 2024; profit after tax increased to €955 million.

• Consumer business net sales reached €8.2 billion, with 2.5% organic growth; tesa net sales at €1.7 billion, 1.8% organic growth.

• EBIT (excluding special factors) increased to €1.4 billion, with a 10 bps margin increase.

• Group gross margin declined to 57.7%; consumer gross margin fell 70 bps to 60.3%.

Outlook and guidance

• 2026 guidance expects flat to slightly positive organic sales growth across all segments, with EBIT margin slightly below 2025 due to raw material costs, FX, and limited fixed cost leverage.

• Q1 2026 anticipated to be low single-digit negative due to US and China retail disruptions.

• Strategic focus on returning NIVEA to growth, continued innovation, and expansion into white spaces.

• No specific EBIT or EPS guidance for 2027, but commitment to profitable growth remains.

• Commitment to improved shareholder returns via share buybacks and dividends.